Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes

doi:10.1084/jem.182.1.255

This Article

	Full Text (PDF, 597K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Porgador, A.
	Articles by Gilboa, E.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Porgador, A.
	Articles by Gilboa, E.


Social Bookmarking

	What's this?

ARTICLES

Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes

A Porgador and E Gilboa
Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA.

It has previously been shown that bone marrow-generated dendritic cells (DC) are potent stimulators in allogeneic mixed leukocyte reactions and are capable of activating naive CD4+ T cells in situ in an antigen- specific manner. In this study we have investigated whether bone marrow- generated DC are capable of inducing antigen-specific CD8+ T cell responses in vivo. Initial attempts to induce specific cytotoxic T lymphocyte (CTL) responses in mice injected with bone marrow-generated DC pulsed with ovalbumin (OVA) peptide were frustrated by the presence of high levels of nonspecific lytic activity, which obscured, though not completely, the presence of Ag-specific CTL. Using conditions that effectively differentiate between antigen-specific and nonspecific lytic activity, we have shown that bone marrow-generated DC pulsed with OVA peptide are potent inducers of OVA-specific CTL responses in vivo, compared with splenocytes or RMA-S cells pulsed with OVA peptide, or compared with immunization with free OVA peptide mixed with adjuvant. Antibody-mediated depletion experiments have shown that the cytotoxic effector cells consist primarily of CD8+ cells, and that induction of CTL in vivo is dependent on CD4+ as well as on CD8+ T cells. These results provide the basis for exploring the role of bone marrow- generated DC in major histocompatibility class I-restricted immune responses, and they provide the rationale for using bone marrow- generated DC in CTL-mediated immunotherapy of cancer and infectious diseases.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Lopez, M. N., Pereda, C., Segal, G., Munoz, L., Aguilera, R., Gonzalez, F. E., Escobar, A., Ginesta, A., Reyes, D., Gonzalez, R., Mendoza-Naranjo, A., Larrondo, M., Compan, A., Ferrada, C., Salazar-Onfray, F. (2009). Prolonged Survival of Dendritic Cell-Vaccinated Melanoma Patients Correlates With Tumor-Specific Delayed Type IV Hypersensitivity Response and Reduction of Tumor Growth Factor {beta}-Expressing T Cells. JCO 27: 945-952 [Abstract] [Full Text]
Savai, R., Schermuly, R. T., Pullamsetti, S. S., Schneider, M., Greschus, S., Ghofrani, H. A., Traupe, H., Grimminger, F., Banat, G.-A. (2007). A Combination Hybrid-Based Vaccination/Adoptive Cellular Therapy to Prevent Tumor Growth by Involvement of T Cells. Cancer Res. 67: 5443-5453 [Abstract] [Full Text]
Uto, T., Wang, X., Sato, K., Haraguchi, M., Akagi, T., Akashi, M., Baba, M. (2007). Targeting of Antigen to Dendritic Cells with Poly({gamma}-Glutamic Acid) Nanoparticles Induces Antigen-Specific Humoral and Cellular Immunity. J. Immunol. 178: 2979-2986 [Abstract] [Full Text]
Grolleau-Julius, A., Garg, M. R., Mo, R., Stoolman, L. L., Yung, R. L. (2006). Effect of Aging on Bone Marrow-Derived Murine CD11c+CD4-CD8{alpha}- Dendritic Cell Function.. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 61: 1039-1047 [Abstract] [Full Text]
Hu, J., Yuan, X., Belladonna, M. L., Ong, J. M., Wachsmann-Hogiu, S., Farkas, D. L., Black, K. L., Yu, J. S. (2006). Induction of Potent Antitumor Immunity by Intratumoral Injection of Interleukin 23-Transduced Dendritic Cells.. Cancer Res. 66: 8887-8896 [Abstract] [Full Text]
Yoon, M.-S., Lee, J. S., Choi, B.-M., Jeong, Y.-I., Lee, C.-M., Park, J.-H., Moon, Y., Sung, S.-C., Lee, S. K., Chang, Y. H., Chung, H. Y., Park, Y.-M. (2006). Apigenin Inhibits Immunostimulatory Function of Dendritic Cells: Implication of Immunotherapeutic Adjuvant. Mol. Pharmacol. 70: 1033-1044 [Abstract] [Full Text]
Haase, C., Ejrnaes, M., Juedes, A. E., Wolfe, T., Markholst, H., von Herrath, M. G. (2005). Immunomodulatory dendritic cells require autologous serum to circumvent nonspecific immunosuppressive activity in vivo. Blood 106: 4225-4233 [Abstract] [Full Text]
Kim, G.-Y., Kim, K.-H., Lee, S.-H., Yoon, M.-S., Lee, H.-J., Moon, D.-O., Lee, C.-M., Ahn, S.-C., Park, Y. C., Park, Y.-M. (2005). Curcumin Inhibits Immunostimulatory Function of Dendritic Cells: MAPKs and Translocation of NF-{kappa}B as Potential Targets. J. Immunol. 174: 8116-8124 [Abstract] [Full Text]
Groh, V., Li, Y. Q., Cioca, D., Hunder, N. N., Wang, W., Riddell, S. R., Yee, C., Spies, T. (2005). From The Cover: Efficient cross-priming of tumor antigen-specific T cells by dendritic cells sensitized with diverse anti-MICA opsonized tumor cells. Proc. Natl. Acad. Sci. USA 102: 6461-6466 [Abstract] [Full Text]
Bloushtain, N., Qimron, U., Bar-Ilan, A., Hershkovitz, O., Gazit, R., Fima{dagger}, E., Korc, M., Vlodavsky, I., Bovin, N. V., Porgador, A. (2004). Membrane-Associated Heparan Sulfate Proteoglycans Are Involved in the Recognition of Cellular Targets by NKp30 and NKp46. J. Immunol. 173: 2392-2401 [Abstract] [Full Text]
Caruso, D. A., Orme, L. M., Neale, A. M., Radcliff, F. J., Amor, G. M., Maixner, W., Downie, P., Hassall, T. E., Tang, M. L.K., Ashley, D. M. (2004). Results of a phase 1 study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children and young adults with brain cancer. Neuro Oncol Duke 6: 236-246 [Abstract]
Behrens, G. M. N., Li, M., Davey, G. M., Allison, J., Flavell, R. A., Carbone, F. R., Heath, W. R. (2004). Helper Requirements for Generation of Effector CTL to Islet {beta} Cell Antigens. J. Immunol. 172: 5420-5426 [Abstract] [Full Text]
Wang, J.-C. E., Livingstone, A. M. (2003). Cutting Edge: CD4+ T Cell Help Can Be Essential for Primary CD8+ T Cell Responses In Vivo. J. Immunol. 171: 6339-6343 [Abstract] [Full Text]
van den Broeke, L. T., Daschbach, E., Thomas, E. K., Andringa, G., Berzofsky, J. A. (2003). Dendritic Cell-Induced Activation of Adaptive and Innate Antitumor Immunity. J. Immunol. 171: 5842-5852 [Abstract] [Full Text]
Wiethe, C., Dittmar, K., Doan, T., Lindenmaier, W., Tindle, R. (2003). Enhanced Effector and Memory CTL Responses Generated by Incorporation of Receptor Activator of NF-{kappa}B (RANK)/RANK Ligand Costimulatory Molecules into Dendritic Cell Immunogens Expressing a Human Tumor-Specific Antigen. J. Immunol. 171: 4121-4130 [Abstract] [Full Text]
Dayball, K., Millar, J., Miller, M., Wan, Y. H., Bramson, J. (2003). Electroporation Enables Plasmid Vaccines to Elicit CD8+ T Cell Responses in the Absence of CD4+ T Cells. J. Immunol. 171: 3379-3384 [Abstract] [Full Text]
Davila, E., Kennedy, R., Celis, E. (2003). Generation of Antitumor Immunity by Cytotoxic T Lymphocyte Epitope Peptide Vaccination, CpG-oligodeoxynucleotide Adjuvant, and CTLA-4 Blockade. Cancer Res. 63: 3281-3288 [Abstract] [Full Text]
Muller, M. R., Grunebach, F., Nencioni, A., Brossart, P. (2003). Transfection of Dendritic Cells with RNA Induces CD4- and CD8-Mediated T Cell Immunity Against Breast Carcinomas and Reveals the Immunodominance of Presented T Cell Epitopes. J. Immunol. 170: 5892-5896 [Abstract] [Full Text]
Saha, A., Chatterjee, S. K., Foon, K. A., Primus, F. J., Bhattacharya-Chatterjee, M. (2003). Murine Dendritic Cells Pulsed with an Anti-Idiotype Antibody Induce Antigen-specific Protective Antitumor Immunity. Cancer Res. 63: 2844-2854 [Abstract] [Full Text]
Eriksson, K., Fredriksson, M., Nordstrom, I., Holmgren, J. (2003). Cholera Toxin and Its B Subunit Promote Dendritic Cell Vaccination with Different Influences on Th1 and Th2 Development. Infect. Immun. 71: 1740-1747 [Abstract] [Full Text]
Kao, J. Y., Gong, Y., Chen, C.-M., Zheng, Q.-D., Chen, J.-J. (2003). Tumor-Derived TGF-{beta} Reduces the Efficacy of Dendritic Cell/Tumor Fusion Vaccine. J. Immunol. 170: 3806-3811 [Abstract] [Full Text]
Wiethe, C., Dittmar, K., Doan, T., Lindenmaier, W., Tindle, R. (2003). Provision of 4-1BB Ligand Enhances Effector and Memory CTL Responses Generated by Immunization with Dendritic Cells Expressing a Human Tumor-Associated Antigen. J. Immunol. 170: 2912-2922 [Abstract] [Full Text]
Butterfield, L. H., Ribas, A., Dissette, V. B., Amarnani, S. N., Vu, H. T., Oseguera, D., Wang, H.-J., Elashoff, R. M., McBride, W. H., Mukherji, B., Cochran, A. J., Glaspy, J. A., Economou, J. S. (2003). Determinant Spreading Associated with Clinical Response in Dendritic Cell-based Immunotherapy for Malignant Melanoma. Clin. Cancer Res. 9: 998-1008 [Abstract] [Full Text]
Oh, S., Hodge, J. W., Ahlers, J. D., Burke, D. S., Schlom, J., Berzofsky, J. A. (2003). Selective Induction of High Avidity CTL by Altering the Balance of Signals from APC. J. Immunol. 170: 2523-2530 [Abstract] [Full Text]
Gatza, E., Okada, C. Y. (2002). Tumor Cell Lysate-Pulsed Dendritic Cells Are More Effective Than TCR Id Protein Vaccines for Active Immunotherapy of T Cell Lymphoma. J. Immunol. 169: 5227-5235 [Abstract] [Full Text]
Hebart, H., Daginik, S., Stevanovic, S., Grigoleit, U., Dobler, A., Baur, M., Rauser, G., Sinzger, C., Jahn, G., Loeffler, J., Kanz, L., Rammensee, H.-G., Einsele, H. (2002). Sensitive detection of human cytomegalovirus peptide-specific cytotoxic T-lymphocyte responses by interferon-gamma -enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation. Blood 99: 3830-3837 [Abstract] [Full Text]
Kemp, R. A., Ronchese, F. (2001). Tumor-Specific Tc1, But Not Tc2, Cells Deliver Protective Antitumor Immunity. J. Immunol. 167: 6497-6502 [Abstract] [Full Text]
Fujii, S.-i., Shimizu, K., Shimizu, T., Lotze, M. T. (2001). Interleukin-10 promotes the maintenance of antitumor CD8+ T-cell effector function in situ. Blood 98: 2143-2151 [Abstract] [Full Text]
Motta, I., Andre, F., Lim, A., Tartaglia, J., Cox, W. I., Zitvogel, L., Angevin, E., Kourilsky, P. (2001). Cross-Presentation by Dendritic Cells of Tumor Antigen Expressed in Apoptotic Recombinant Canarypox Virus-Infected Dendritic Cells. J. Immunol. 167: 1795-1802 [Abstract] [Full Text]
Zhu, M., Terasawa, H., Gulley, J., Panicali, D., Arlen, P., Schlom, J., Tsang, K. Y. (2001). Enhanced Activation of Human T Cells via Avipox Vector-mediated Hyperexpression of a Triad of Costimulatory Molecules in Human Dendritic Cells. Cancer Res. 61: 3725-3734 [Abstract] [Full Text]
Berard, F., Blanco, P., Davoust, J., Neidhart-Berard, E.-M., Nouri-Shirazi, M., Taquet, N., Rimoldi, D., Cerottini, J. C., Banchereau, J., Palucka, A. K. (2000). Cross-Priming of Naive Cd8 T Cells against Melanoma Antigens Using Dendritic Cells Loaded with Killed Allogeneic Melanoma Cells. JEM 192: 1535-1544 [Abstract] [Full Text]
Warren, T. L., Bhatia, S. K., Acosta, A. M., Dahle, C. E., Ratliff, T. L., Krieg, A. M., Weiner, G. J. (2000). APC Stimulated by CpG Oligodeoxynucleotide Enhance Activation of MHC Class I-Restricted T Cells. J. Immunol. 165: 6244-6251 [Abstract] [Full Text]
Boudinot, P., Riffault, S., Salhi, S., Carrat, C., Sedlik, C., Mahmoudi, N., Charley, B., Benmansour, A. (2000). Vesicular stomatitis virus and pseudorabies virus induce a vig1/cig5 homologue in mouse dendritic cells via different pathways. J. Gen. Virol. 81: 2675-2682 [Abstract] [Full Text]
Brossart, P., Wirths, S., Stuhler, G., Reichardt, V. L., Kanz, L., Brugger, W. (2000). Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells. Blood 96: 3102-3108 [Abstract] [Full Text]
Tanaka, F., Hashimoto, W., Okamura, H., Robbins, P. D., Lotze, M. T., Tahara, H. (2000). Rapid Generation of Potent and Tumor-specific Cytotoxic T Lymphocytes by Interleukin 18 Using Dendritic Cells and Natural Killer Cells. Cancer Res. 60: 4838-4844 [Abstract] [Full Text]
Brossart, P., Zobywalski, A., Grünebach, F., Behnke, L., Stuhler, G., Reichardt, V. L., Kanz, L., Brugger, W. (2000). Tumor Necrosis Factor {{alpha}} and CD40 Ligand Antagonize the Inhibitory Effects of Interleukin 10 on T-Cell Stimulatory Capacity of Dendritic Cells. Cancer Res. 60: 4485-4492 [Abstract] [Full Text]
Kodaira, Y., Nair, S. K., Wrenshall, L. E., Gilboa, E., Platt, J. L. (2000). Phenotypic and Functional Maturation of Dendritic Cells Mediated by Heparan Sulfate. J. Immunol. 165: 1599-1604 [Abstract] [Full Text]
Doan, T., Herd, K. A., Lambert, P. F., Fernando, G. J. P., Street, M. D., Tindle, R. W. (2000). Peripheral Tolerance to Human Papillomavirus E7 Oncoprotein Occurs by Cross-Tolerization, Is Largely Th-2-independent, and Is Broken by Dendritic Cell Immunization. Cancer Res. 60: 2810-2815 [Abstract] [Full Text]
Timmerman, J. M., Levy, R. (2000). Linkage of Foreign Carrier Protein to a Self-Tumor Antigen Enhances the Immunogenicity of a Pulsed Dendritic Cell Vaccine. J. Immunol. 164: 4797-4803 [Abstract] [Full Text]
Yang, S., Kittlesen, D., Slingluff, C. L. Jr., Vervaert, C. E., Seigler, H. F., Darrow, T. L. (2000). Dendritic Cells Infected with a Vaccinia Vector Carrying the Human gp100 Gene Simultaneously Present Multiple Specificities and Elicit High-Affinity T Cells Reactive to Multiple Epitopes and Restricted by HLA-A2 and -A3. J. Immunol. 164: 4204-4211 [Abstract] [Full Text]
Ribas, A., Butterfield, L. H., Hu, B., Dissette, V. B., Meng, W. S., Koh, A., Andrews, K. J., Lee, M., Amar, S. N., Glaspy, J. A., McBride, W. H., Economou, J. S. (2000). Immune Deviation and Fas-mediated Deletion Limit Antitumor Activity after Multiple Dendritic Cell Vaccinations in Mice. Cancer Res. 60: 2218-2224 [Abstract] [Full Text]
Bullock, T. N. J., Colella, T. A., Engelhard, V. H. (2000). The Density of Peptides Displayed by Dendritic Cells Affects Immune Responses to Human Tyrosinase and gp100 in HLA-A2 Transgenic Mice. J. Immunol. 164: 2354-2361 [Abstract] [Full Text]
Chakravarty, P. K., Alfieri, A., Thomas, E. K., Beri, V., Tanaka, K. E., Vikram, B., Guha, C. (1999). Flt3-Ligand Administration after Radiation Therapy Prolongs Survival in a Murine Model of Metastatic Lung Cancer. Cancer Res. 59: 6028-6032 [Abstract] [Full Text]
de Cerio, A. L.-D., Casares, N., Lasarte, J. J., Sarobe, P., Perez-Mediavilla, L. A., Ruiz, M., Prieto, J., Borras-Cuesta, F. (1999). Th1 but not Th0 cell help is efficient to induce cytotoxic T lymphocytes by immunization with short synthetic peptides. Int Immunol 11: 2025-2034 [Abstract] [Full Text]
Nishioka, Y., Hirao, M., Robbins, P. D., Lotze, M. T., Tahara, H. (1999). Induction of Systemic and Therapeutic Antitumor Immunity Using Intratumoral Injection of Dendritic Cells Genetically Modified to Express Interleukin 12. Cancer Res. 59: 4035-4041 [Abstract] [Full Text]
Eggert, A. A. O., Schreurs, M. W. J., Boerman, O. C., Oyen, W. J. C., de Boer, A. J., Punt, C. J. A., Figdor, C. G., Adema, G. J. (1999). Biodistribution and Vaccine Efficiency of Murine Dendritic Cells Are Dependent on the Route of Administration. Cancer Res. 59: 3340-3345 [Abstract] [Full Text]
Brossart, P., Heinrich, K. S., Stuhler, G., Behnke, L., Reichardt, V. L., Stevanovic, S., Muhm, A., Rammensee, H.-G., Kanz, L., Brugger, W. (1999). Identification of HLA-A2-Restricted T-Cell Epitopes Derived From the MUC1 Tumor Antigen for Broadly Applicable Vaccine Therapies. Blood 93: 4309-4317 [Abstract] [Full Text]
Melcher, A., Todryk, S., Bateman, A., Chong, H., Lemoine, N. R, Vile, R. G (1999). Adoptive Transfer of Immature Dendritic Cells with Autologous or Allogeneic Tumor Cells Generates Systemic Antitumor Immunity. Cancer Res. 59: 2802-2805 [Abstract] [Full Text]
Morse, M. A., Deng, Y., Coleman, D., Hull, S., Kitrell-Fisher, E., Nair, S., Schlom, J., Ryback, M.-E., Lyerly, H. K. (1999). A Phase I Study of Active Immunotherapy with Carcinoembryonic Antigen Peptide (CAP-1)-pulsed, Autologous Human Cultured Dendritic Cells in Patients with Metastatic Malignancies Expressing Carcinoembryonic Antigen. Clin. Cancer Res. 5: 1331-1338 [Abstract] [Full Text]
Fayolle, C., Ladant, D., Karimova, G., Ullmann, A., Leclerc, C. (1999). Therapy of Murine Tumors with Recombinant Bordetella pertussis Adenylate Cyclase Carrying a Cytotoxic T Cell Epitope. J. Immunol. 162: 4157-4162 [Abstract] [Full Text]
Raje, N., Gong, J., Chauhan, D., Teoh, G., Avigan, D., Wu, Z., Chen, D., Treon, S. P., Webb, I. J., Kufe, D. W., Anderson, K. C. (1999). Bone Marrow and Peripheral Blood Dendritic Cells From Patients With Multiple Myeloma Are Phenotypically and Functionally Normal Despite the Detection of Kaposi's Sarcoma Herpesvirus Gene Sequences. Blood 93: 1487-1495 [Abstract] [Full Text]
De Veerman, M., Heirman, C., Van Meirvenne, S., Devos, S., Corthals, J., Moser, M., Thielemans, K. (1999). Retrovirally Transduced Bone Marrow-Derived Dendritic Cells Require CD4+ T Cell Help to Elicit Protective and Therapeutic Antitumor Immunity. J. Immunol. 162: 144-151 [Abstract] [Full Text]
Maecker, H. T., Umetsu, D. T., DeKruyff, R. H., Levy, S. (1998). Cytotoxic T Cell Responses to DNA Vaccination: Dependence on Antigen Presentation via Class II MHC. J. Immunol. 161: 6532-6536 [Abstract] [Full Text]
Cao, X., Zhang, W., He, L., Xie, Z., Ma, S., Tao, Q., Yu, Y., Hamada, H., Wang, J. (1998). Lymphotactin Gene-Modified Bone Marrow Dendritic Cells Act as More Potent Adjuvants for Peptide Delivery to Induce Specific Antitumor Immunity. J. Immunol. 161: 6238-6244 [Abstract] [Full Text]
Brossart, P., Grunebach, F., Stuhler, G., Reichardt, V. L., Mohle, R., Kanz, L., Brugger, W. (1998). Generation of Functional Human Dendritic Cells From Adherent Peripheral Blood Monocytes by CD40 Ligation in the Absence of Granulocyte-Macrophage Colony-Stimulating Factor. Blood 92: 4238-4247 [Abstract] [Full Text]
Wang, J., Saffold, S., Cao, X., Krauss, J., Chen, W. (1998). Eliciting T Cell Immunity Against Poorly Immunogenic Tumors by Immunization with Dendritic Cell-Tumor Fusion Vaccines. J. Immunol. 161: 5516-5524 [Abstract] [Full Text]
Shimizu, Y., Guidotti, L. G., Fowler, P., Chisari, F. V. (1998). Dendritic Cell Immunization Breaks Cytotoxic T Lymphocyte Tolerance in Hepatitis B Virus Transgenic Mice. J. Immunol. 161: 4520-4529 [Abstract] [Full Text]
Mackey, M. F., Gunn, J. R., Maliszewski, C., Kikutani, H., Noelle, R. J., Barth, R. J. Jr. (1998). Cutting Edge: Dendritic Cells Require Maturation via CD40 to Generate Protective Antitumor Immunity. J. Immunol. 161: 2094-2098 [Abstract] [Full Text]
Ahuja, S. S., Mummidi, S., Malech, H. L., Ahuja, S. K. (1998). Human Dendritic Cell (DC)-Based Anti-Infective Therapy: Engineering DCs to Secrete Functional IFN-{gamma} and IL-12. J. Immunol. 161: 868-876 [Abstract] [Full Text]
Gong, J., Chen, D., Kashiwaba, M., Li, Y., Chen, L., Takeuchi, H., Qu, H., Rowse, G. J., Gendler, S. J., Kufe, D. (1998). Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells. Proc. Natl. Acad. Sci. USA 95: 6279-6283 [Abstract] [Full Text]
Ludewig, B., Ehl, S., Karrer, U., Odermatt, B., Hengartner, H., Zinkernagel, R. M. (1998). Dendritic Cells Efficiently Induce Protective Antiviral Immunity. J. Virol. 72: 3812-3818 [Abstract] [Full Text]
Toes, R. E. M., van der Voort, E. I. H., Schoenberger, S. P., Drijfhout, J. W., van Bloois, L., Storm, G., Kast, W. M., Offringa, R., Melief, C. J. M. (1998). Enhancement of Tumor Outgrowth Through CTL Tolerization After Peptide Vaccination Is Avoided by Peptide Presentation on Dendritic Cells. J. Immunol. 160: 4449-4456 [Abstract] [Full Text]
Rescigno, M., Citterio, S., Thery, C., Rittig, M., Medaglini, D., Pozzi, G., Amigorena, S., Ricciardi-Castagnoli, P. (1998). Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells. Proc. Natl. Acad. Sci. USA 95: 5229-5234 [Abstract] [Full Text]
Ashley, D. M., Faiola, B., Nair, S., Hale, L. P., Bigner, D. D., Gilboa, E. (1997). Bone Marrow-generated Dendritic Cells Pulsed with Tumor Extracts or Tumor RNA Induce Antitumor Immunity against Central Nervous System Tumors. JEM 186: 1177-1182 [Abstract] [Full Text]
Szabolcs, P., Gallardo, H.F., Ciocon, D. H., Sadelain, M., Young, J. W. (1997). Retrovirally Transduced Human Dendritic Cells Express a Normal Phenotype and Potent T-Cell Stimulatory Capacity. Blood 90: 2160-2167 [Abstract] [Full Text]
Brossart, P., Bevan, M. J. (1997). Presentation of Exogenous Protein Antigens on Major Histocompatability Complex Class I Molecules by Dendritic Cells: Pathway of Presentation and Regulation by Cytokines. Blood 90: 1594-1599 [Abstract] [Full Text]
Bronte, V., Carroll, M. W., Goletz, T. J., Wang, M., Overwijk, W. W., Marincola, F., Rosenberg, S. A., Moss, B., Restifo, N. P. (1997). Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor�vaccine. Proc. Natl. Acad. Sci. USA 94: 3183-3188 [Abstract] [Full Text]
Choudhury, A., Gajewski, J. L., Liang, J. C., Popat, U., Claxton, D. F., Kliche, K.-O., Andreeff, M., Champlin, R. E. (1997). Use of Leukemic Dendritic Cells for the Generation of Antileukemic Cellular Cytotoxicity Against Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia. Blood 89: 1133-1142 [Abstract] [Full Text]
Siena, S., Di Nicola, M., Mortarini, R., Anichini, A., Bregni, M., Parmiani, G., Gianni, A. M. (1997). Expansion of Immunostimulatory Dendritic Cells from Peripheral Blood of Patients with Cancer. The Oncologist 2: 65-69 [Full Text]